Rubric Capital Management (New York)’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,900,000
| Closed | -$44.7M | – | 99 |
|
|
2022
Q1 | $44.7M | Buy |
10,900,000
+100,000
| +0.9% | +$410K | 1.62% | 16 |
|
|
2021
Q4 | $38.6M | Buy |
10,800,000
+800,000
| +8% | +$2.86M | 1.82% | 22 |
|
|
2021
Q3 | $36.4M | Buy |
10,000,000
+500,000
| +5% | +$1.82M | 1.02% | 23 |
|
|
2021
Q2 | $41.4M | Buy |
9,500,000
+777,353
| +9% | +$3.39M | 2.61% | 17 |
|
|
2021
Q1 | $35.9M | Buy |
8,722,647
+5,152,084
| +144% | +$21.2M | 2.09% | 21 |
|
|
2020
Q4 | $14.2M | Buy |
+3,570,563
| New | +$14.2M | 1.05% | 36 |
|
|
2019
Q1 | – | Sell |
-12,865
| Closed | -$35K | – | 72 |
|
|
2018
Q4 | $35K | Buy |
+12,865
| New | +$35K | ﹤0.01% | 48 |
|
|
2017
Q4 | – | Sell |
-324,076
| Closed | -$1.05M | – | 63 |
|
|
2017
Q3 | $1.05M | Sell |
324,076
-2,864,524
| -90% | -$9.28M | 0.1% | 49 |
|
|
2017
Q2 | $10.3M | Buy |
3,188,600
+816,630
| +34% | +$2.63M | 2.12% | 20 |
|
|
2017
Q1 | $6.74M | Buy |
2,371,970
+1,207,622
| +104% | +$3.43M | 1.96% | 23 |
|
|
2016
Q4 | $2.71M | Buy |
+1,164,348
| New | +$2.71M | 0.93% | 21 |
|